Mark P Nicol (Mark Nicol)

ResearcherID Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 16

Top Topics

Human Immunodeficiency Virus

Pulmonary Tuberculosis

Top Venues

Wellcome open research

Southern African journal of HIV medicine

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

This page only lists publications with an associated author ORCID identifier.

Publications

Lindy Dickson, Sacha Roxanne Le Roux, Leila Mitrani, Jeremy Hill, Waasila Jassat, Helen Cox, Koleka Mlisana, John Black, Marian Loveday, Alison Grant, Karina Kielmann, Norbert Ndjeka, Mosa Moshabela, Mark P Nicol
Organisation of care for people receiving drug-resistant tuberculosis treatment in South Africa: a mixed methods study. BMJ open 13 (11) (2023)
Ruan Spies, Charlotte Schutz, Amy Ward, Avuyonke Balfour, Muki Shehu Shey, Mark P Nicol, Rosie Burton, Bianca Sossen, Robert John Wilkinson, David A Barr, Graeme Meintjes
Rifampicin resistance and mortality in patients hospitalised with HIV-associated tuberculosis. Southern African journal of HIV medicine 23 (1) (2022)
Tobias Broger, Mark P Nicol
A Novel Bedside Rule-in Test for Tuberculous Meningitis in Human Immunodeficiency Virus-Infected Adults. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 73 (9) (2021)
Imane Allali, Regina E Abotsi, Lemese Ah Tow, Lehana Thabane, Heather J Zar, Nicola M Mulder, Mark P Nicol
Human microbiota research in Africa: a systematic review reveals gaps and priorities for future research. Microbiome 9 (1) (2021)
Mark P Nicol, Samuel G Schumacher, Lesley Workman, Tobias Broger, Cynthia Baard, Margaretha Prins, Lindy Bateman, Elloise du Toit, Judi van Heerden, Rita Szekely, Heather J Zar, Claudia M Denkinger
Accuracy of a Novel Urine Test, Fujifilm SILVAMP Tuberculosis Lipoarabinomannan, for the Diagnosis of Pulmonary Tuberculosis in Children. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 72 (9) (2021)
Tobias Broger, Mark P Nicol, Rita Székely, Stephanie Bjerrum, Bianca Sossen, Charlotte Schutz, Japheth A Opintan, Isik S Johansen, Satoshi Mitarai, Kinuyo Chikamatsu, Andrew D Kerkhoff, Aurélien Mace, Stefano Ongarello, Graeme Meintjes, Claudia M Denkinger, Samuel G Schumacher
Diagnostic accuracy of a novel tuberculosis point-of-care urine lipoarabinomannan assay for people living with HIV: A meta-analysis of individual in- and outpatient data. PLoS medicine 17 (5) (2020)
Eleanor A Ochodo, Nelson Kalema, Samuel G Schumacher, Karen Steingart, Taryn Young, Susan Mallett, Jon Deeks, Frank Cobelens, Patrick M M Bossuyt, Mark P Nicol, Adithya Cattamanchi
Variation in the observed effect of Xpert MTB/RIF testing for tuberculosis on mortality: A systematic review and analysis of trial design considerations. Wellcome open research 4 (2020)
Charlotte Schutz, David Barr, Bruno Bezerril Andrade, Muki Shehu Shey, Amy Ward, Saskia Janssen, Rosie Burton, Katalin Andrea Wilkinson, Bianca Sossen, Kiyoshi F Fukutani, Mark P Nicol, Gary Maartens, Robert John Wilkinson, Graeme Meintjes
Clinical, microbiologic, and immunologic determinants of mortality in hospitalized patients with HIV-associated tuberculosis: A prospective cohort study. PLoS medicine 16 (7) (2019)
Eleanor A Ochodo, Nelson Kalema, Samuel G Schumacher, Karen Steingart, Taryn Young, Susan Mallett, Jon Deeks, Frank Cobelens, Patrick M M Bossuyt, Mark P Nicol, Adithya Cattamanchi
Variation in the observed effect of Xpert MTB/RIF testing for tuberculosis on mortality: A systematic review and analysis of trial design considerations. Wellcome open research (2019)
Andrea L Young, Mark P Nicol, Clinton Moodley, Colleen M Bamford
The accuracy of extended-spectrum beta-lactamase detection in Escherichia coli and Klebsiella pneumoniae in South African laboratories using the Vitek 2 Gram-negative susceptibility card AST-N255. Southern African journal of infectious diseases 34 (1) (2019)
Eleanor A Ochodo, Selvan Naidoo, Samuel G Schumacher, Karen Steingart, Jon Deeks, Frank Cobelens, Patrick M M Bossuyt, Taryn Young, Mark P Nicol
Improving the design of studies evaluating the impact of diagnostic tests for tuberculosis on health outcomes: a qualitative study of perspectives of diverse stakeholders. Wellcome open research 4 (2019)
Anthony Marius Smith, Nomsa P Tau, John Bosco Kalule, Mark P Nicol, Mignon I McCulloch, Charlene A Jacobs, Kerrigan M McCarthy, Arshad Ismail, Mushal Allam, Jackie Kleynhans
Shiga toxin-producing Escherichia coli O26:H11 associated with a cluster of haemolytic uraemic syndrome cases in South Africa, 2017. Access microbiology 1 (9) (2019)
Mark P Nicol, Rachel C Wood, Lesley Workman, Margaretha Prins, Cynthia Whitman, Yonas Ghebrekristos, Slindile Mbhele, Alaina Olson, Lisa E Jones-Engel, Heather J Zar, Gerard A Cangelosi
Microbiological diagnosis of pulmonary tuberculosis in children by oral swab polymerase chain reaction. Scientific reports 9 (1) (2019)
Charlotte Schutz, Amy Ward, Rosie Burton, Mark P Nicol, Lisette Blumenthal, Graeme Meintjes, Andrew D Kerkhoff
False rifampicin resistant results using Xpert MTB/RIF on urine samples in hospitalised HIV-infected patients. Southern African journal of HIV medicine 20 (1) (2019)
Gary Maartens, Annemie Stewart, Rulan Griesel, Andre Pascal Kengne, Felix Dube, Mark P Nicol, Molebogeng X Rangaka, Marc Mendelson
Development of a clinical prediction rule to diagnose Pneumocystis jirovecii pneumonia in the World Health Organization's algorithm for seriously ill HIV-infected patients. Southern African journal of HIV medicine 19 (1) (2018)
Richard J Lessells, Graham S Cooke, Nuala McGrath, Mark P Nicol, Marie-Louise Newell, Peter Godfrey-Faussett
Impact of Point-of-Care Xpert MTB/RIF on Tuberculosis Treatment Initiation. A Cluster-randomized Trial. American journal of respiratory and critical care medicine 196 (7) (2017)